Nomascus leucogenys (northern white-cheeked gibbon)
| UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
|---|---|---|---|---|---|
| G1QV31 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
| A0A2I3HKE6 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
| A0A2I3HYQ1 | Angiotensin-converting enzyme |
|
6 | 0 |
|
| G1S0D0 | N-acetylgalactosamine-6-sulfatase |
|
2 | 0 |
|
| Q07DX8 | Suppressor of tumorigenicity 7 protein |
|
1 | 0 |
|
| A0A2I3GXY6 | Fibroblast growth factor receptor |
|
8 | 0 |
|
| G1RSC1 | Cathepsin D |
|
2 | 0 |
|
| G1RB84 | Peptidase A1 domain-containing protein |
|
2 | 0 |
|
| A0A2I3HK83 | P2X purinoceptor |
|
1 | 0 |
|
| G1R5P0 | Hyaluronidase-3 |
|
1 | 0 |
|
| A0A2I3HH16 | GDNF family receptor alpha-1 |
|
2 | 0 |
|
| G1S2Y7 | GDNF family receptor alpha-1 |
|
2 | 0 |
|
| A0A2I3FQ03 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A2I3GR19 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| Q07DX5 | Cystic fibrosis transmembrane conductance regulator |
|
2 | 0 |
|
| G1S8X0 | Voltage-dependent L-type calcium channel subunit alpha |
|
2 | 0 |
|
| G1R9A7 | P2X purinoceptor |
|
1 | 0 |
|
| A0A2I3H2F6 | Hyaluronidase |
|
1 | 0 |
|
| A0A2I3HYW4 | Angiotensin-converting enzyme |
|
12 | 0 |
|
| G1R5P3 | Hyaluronidase |
|
1 | 0 |
|
| A0A2I3HGL4 | Noggin |
|
1 | 0 |
|
| G1RRP1 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
| G1R9B5 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| G1QQW7 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| G1R636 | Pannexin |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025